Luo Mary Z.
Known title: COO,Chief Scientist & ChairmanCIK: 0001611156
Associated companies
Transaction History
| AMPH | ▼ Sell | Open Market | 78,236 | $4.2M | 1/10/2024 | View on chart |
| AMPH | ▼ Sell | Open Market | 50,514 | $2.8M | 1/10/2024 | View on chart |
| AMPH | ▼ Sell | Open Market | 920 | $51K | 1/10/2024 | View on chart |
| AMPH | ▼ Sell | Open Market | 1,716 | $98K | 1/10/2024 | View on chart |
| AMPH | ▼ Sell | Open Market | 3,714 | $217K | 1/9/2024 | View on chart |
| AMPH | ▼ Sell | Open Market | 50,678 | $2.9M | 1/9/2024 | View on chart |
| AMPH | ▼ Sell | Open Market | 31,764 | $1.8M | 1/9/2024 | View on chart |
| AMPH | ▼ Sell | Open Market | 27,563 | $1.7M | 1/8/2024 | View on chart |
| AMPH | ▼ Sell | Open Market | 1,663 | $103K | 1/8/2024 | View on chart |
| AMPH | ▼ Sell | Open Market | 2,152 | $136K | 1/8/2024 | View on chart |
| AMPH | ▼ Sell | Open Market | 4,261 | $261K | 1/8/2024 | View on chart |
| AMPH | ▼ Sell | Open Market | 18,858 | $1.1M | 1/8/2024 | View on chart |
| AMPH | ▼ Sell | Open Market | 41,282 | $2.4M | 1/8/2024 | View on chart |
| AMPH | ▼ Sell | Open Market | 37,865 | $2.2M | 1/8/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Amphastar (AMPH) Cited as Safe-and-Steady Stock in Yahoo Analysis
A recent Yahoo Finance article highlighted Amphastar Pharmaceuticals as a 'safe-and-steady' stock worth researching further. This positive framing contrasts with other companies facing challenges, suggesting the market views AMPH as a relatively stable option. The stock currently trades with a trailing P/E of 14.2, which is lower than the average analyst target price of $22.50.
Amphastar (AMPH) Cited as Safe-and-Steady Stock in Yahoo Analysis. A recent Yahoo Finance article highlighted Amphastar Pharmaceuticals as a 'safe-and-steady' stock worth researching further. This positive framing contrasts with other companies facing challenges, suggesting the market views AMPH as a relatively stable option. The stock currently trades with a trailing P/E of 14.2, which is lower than the average analyst target price of $22.50.